Jacob came to Viralgen in 2023 from AskBio, where he served as VP of Process Development and Manufacturing for six years, and where he led the development of the Pro10™ cell line-based manufacturing system, now known as the Aava platform. His industry experience includes roles at Pfizer, Bamboo Therapeutics, and UNC Chapel Hill Gene Therapy Center & Vector Core. He has extensive experience in molecular biology and virology, with special expertise in natural product isolation and identification, DNA sequencing and analysis, and AAV vector design and production, as well as manufacturing process development, implementation, and technology transfer.